Berry Oncology

China
Foochow, Fujian, China

Company profile

Berry Oncology company profile

Berry Oncology develops medical technology intended to improve cancer prevention and tumor diagnosis. It offers genetic diagnosis solutions from early diagnosis to mid-late monitoring that can solve clinical problems in the direction of several malignant tumors, providing patients with a higher quality of life and reduced risk of cancer. The company's mission is early diagnosis and early treatment of all tumors, all patients receive precise treatment. Along with its vision to become a global icon in the field of early screening and early diagnosis of tumors and a leader in China's tumor gene testing market.

Business identity

Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2017-01-01, Year

Headquarters

Country code
CN
Continent
Asia

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
3
Total equity funding
$230.4M
Last funding
Series B / $99.2M / 2021-08-05
Last equity funding
Series B / $99.2M
Investors
10
Lead investors
2
Articles
12

Founders and investors

Lead investors

China Merchants Venture CapitalQiming Venture Partners

Investors

Boyu CapitalChina Merchants Venture CapitalLegend CapitalQiming Venture PartnersYingke Capital